Back

Stereotactic arrhythmia radioablation - A systematic review and meta-analysis of the prospective clinical studies

1 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Stereotactic-guided and other novel catheter ablative procedures for ventricular arrhythmias Radiotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Wiert Hoeksema

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
3D target definition and initial results from the electroanatomic substrate-guided stereotactic ablative radiotherapy for refractory ventricular tachycardia (ELSTAR-VT)
Miss Y. Kaya (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Preliminary results of the non-invasive cardiac radioablation for ventricular tachycardia study; an in silico dosimetric comparison of photon vs proton radiotherapy for ventricular arrhythmias
Doctor L. Vicini Scajola (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Targeting ventricular tachycardia originating from the anterolateral papillary muscle with stereotactic body radioablation therapy
Doctor M. Pirbaglou (Newmarket, CA)
Abstract Slides Video
Presentation thumbnail
Cardiac motion in patients with ventricular tachycardia: potential implications for the treatment of patients candidates to stereotactic arrhythmia radio-ablation (STAR)
Doctor L. Vicini Scajola (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Machine-learning models to predict the risk of recurrent VT following catheter ablation in patients with structural heart disease
Doctor P. Futela (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Stereotactic-guided and other novel catheter ablative procedures for ventricular arrhythmias

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Stereotactic arrhythmia radioablation in refractory ventricular tachycardia: a systematic review and meta-analysis of efficacy and survival outcomes
thumbnail
Congress Presentation
Middle-term safety and efficacy after stereotactic arrhythmia radiotherapy: results from the prospective STARNL registry
thumbnail
Congress Presentation
Increase in ventricular tachycardia burden during the blanking period after stereotactic arrhythmia radioablation - preliminary results from the CREVET study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources